Fischer Medical Ventures files FY26 BRSR with zero safety incidents
- Fischer Medical Ventures filed its FY26 BRSR with zero workplace accidents
- Standalone reporting shows energy use fell to 193.76 GJ from 2,160.89 GJ
- Employee welfare spending surged to 11.59% of revenue from 0.48%
- Total headcount reduced to 19 employees under standalone metrics

*this image is generated using AI for illustrative purposes only.
Fischer Medical Ventures submitted its Business Responsibility and Sustainability Report (BRSR) for FY26, highlighting a record of zero workplace accidents and full compliance with safety standards. The filing marks a transition to standalone reporting, offering a focused view of the parent entity’s operational metrics.
The company reported a paid-up capital of ₹65.45 crore as of the fiscal year-end. Operations remain concentrated in India, with one plant and two offices serving markets across nine states. The entity serves a B2B customer base comprising diagnostic centers, hospitals, and government health institutions.
Workforce and Safety Metrics
Fischer Medical Ventures employed 19 individuals at the end of FY26, comprising 16 permanent employees and three non-permanent staff. The workforce is predominantly male, accounting for 78.95% of total headcount. The board of directors includes two women, representing 25% of the total composition.
Safety performance remained strong throughout the year. The Lost Time Injury Frequency Rate (LTIFR) stood at zero for both current and previous fiscal years. No fatalities or high-consequence injuries were recorded. All plants and offices underwent 100% assessment for health and safety practices.
| Metric | FY26 | FY25 |
|---|---|---|
| Total Employees | 19 | 49 |
| Female Representation | 21.05% | Data unavailable |
| LTIFR | 0 | 0 |
| Workplace Accidents | 0 | 0 |
Environmental Performance
Environmental disclosures reflect a significant reduction in energy consumption compared to the prior year, driven by the shift from consolidated to standalone reporting. Total energy consumed from non-renewable sources fell to 193.76 GJ in FY26, down from 2,160.89 GJ in FY25. Consequently, energy intensity per rupee of turnover dropped sharply to 1.11 GJ/₹ crore from 1,952.30 GJ/₹ crore.
Greenhouse gas emissions followed a similar trajectory. Scope 2 emissions decreased to 38.21 metric tonnes of CO2 equivalent, compared to 436.074 metric tonnes in FY25. Scope 1 emissions were negligible at 0.00 metric tonnes. Water withdrawal totaled 48.94 kiloliters, sourced entirely from third parties.
Governance and Stakeholder Engagement
The company maintained strict governance protocols, reporting no fines, penalties, or regulatory actions during the year. Two complaints were filed by shareholders and two by employees, all of which were resolved with no pending queries. Anti-corruption policies are embedded within the Code of Conduct, and 100% of employees received training on human rights and code of conduct issues.
What the Numbers Show
The divergence between employee turnover rates and benefit coverage warrants attention. While the permanent employee turnover rate rose to 14.29% in FY26 from 9.00% in FY25, the company expanded its welfare spending significantly. Expenditure on employee well-being measures jumped to 11.59% of total revenue, up from just 0.48% in the previous year. This suggests a strategic pivot toward retaining talent through enhanced benefits rather than volume hiring.
Historical Stock Returns for Fischer Medical Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.89% | +0.79% | -5.73% | -1.54% | -67.24% | 0.0% |
How might the significant reduction in headcount from 49 to 19 employees impact Fischer Medical Ventures' production capacity and future revenue growth?
Will the shift to standalone reporting continue to mask the company's total environmental footprint, and when will consolidated data be available for accurate year-over-year comparison?
Given the sharp rise in permanent employee turnover to 14.29%, will increased welfare spending effectively retain talent, or does this indicate deeper operational or cultural challenges?


































